BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 15698945)

  • 1. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
    Duguépéroux I; De Braekeleer M;
    J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960.
    Scotet V; Gillet D; Duguépéroux I; Audrézet MP; Bellis G; Garnier B; Roussey M; Rault G; Parent P; De Braekeleer M; Férec C;
    Hum Genet; 2002 Sep; 111(3):247-54. PubMed ID: 12215837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis at the Reunion Island (France): spectrum of mutations and genotype-phenotype for the Y122X mutation.
    Duguépéroux I; Bellis G; Lesure JF; Renouil M; Flodrops H; De Braekeleer M
    J Cyst Fibros; 2004 Aug; 3(3):185-8. PubMed ID: 15463906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
    Alibakhshi R; Zamani M
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France.
    Claustres M; Guittard C; Bozon D; Chevalier F; Verlingue C; Ferec C; Girodon E; Cazeneuve C; Bienvenu T; Lalau G; Dumur V; Feldmann D; Bieth E; Blayau M; Clavel C; Creveaux I; Malinge MC; Monnier N; Malzac P; Mittre H; Chomel JC; Bonnefont JP; Iron A; Chery M; Georges MD
    Hum Mutat; 2000; 16(2):143-56. PubMed ID: 10923036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
    Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
    J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France.
    des Georges M; Guittard C; Altiéri JP; Templin C; Sarles J; Sarda P; Claustres M
    J Cyst Fibros; 2004 Dec; 3(4):265-72. PubMed ID: 15698946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiologic study of the cystic fibrosis gene in the Champagne-Ardenne region].
    Clavel C; Pennaforte F; Pigeon F; Mozelle M; Boutterin MC; Duval-Binninger I; F-erec C; Birembaut P
    Ann Biol Clin (Paris); 1996; 54(2):67-74. PubMed ID: 8763629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
    Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
    Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries.
    Feingold J; Guilloud-Bataille M; De Crozes D
    Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
    Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
    Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
    Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
    Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis].
    Repetto G; Poggi H; Harris P; Navarro H; Sánchez I; Guiraldes E; Pérez MA; Boza ML; Hunter B; Wevar ME; Mediavilla M; Foradori A
    Rev Med Chil; 2001 Aug; 129(8):841-7. PubMed ID: 11680956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study.
    Monaghan KG; Feldman GL; Barbarotto GM; Manji S; Desai TK; Snow K
    Am J Med Genet; 2000 Dec; 95(4):361-5. PubMed ID: 11186891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and Ireland.
    Scotet V; Barton DE; Watson JB; Audrézet MP; McDevitt T; McQuaid S; Shortt C; De Braekeleer M; Férec C; Le Maréchal C
    Hum Mutat; 2003 Jul; 22(1):105. PubMed ID: 12815607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients.
    Casals T; Pacheco P; Barreto C; Giménez J; Ramos MD; Pereira S; Pinheiro JA; Cobos N; Curvelo A; Vázquez C; Rocha H; Séculi JL; Pérez E; Dapena J; Carrilho E; Duarte A; Palacio AM; Nunes V; Lavinha J; Estivill X
    Hum Mutat; 1997; 10(5):387-92. PubMed ID: 9375855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
    Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
    J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.